Cedars-Sinai · 1 month ago
Senior Revenue Cycle Analyst (Revenue Integrity)
6500 Wilshire Blvd, Los Angeles, CA, 90048, US
Full-time
Onsite
Senior Level
$85K/yr - $132K/yrCedars-Sinai is a leading healthcare institution known for its commitment to excellence and innovation in patient care. The Senior Revenue Cycle Analyst will be responsible for analyzing trends, developing reports, and making strategic recommendations to improve revenue cycle management.
CommunitiesHealth CareMedicalNon Profit
Responsibilities
Analyze trends to determine where variances are occurring and develop reports to assess these variances
Develop a strategic approach, and make recommendations based upon overall analysis, to effectively monitor areas of opportunity/risk
Assist in developing/creating recurring and ad-hoc reports
Use independent judgment to resolve issues
Create ad hoc reports for distribution to the Director and key management staff within Finance
Qualification
Required
Experience in revenue cycle analysis or related field
Strong analytical skills to assess trends and variances
Ability to develop strategic approaches and make recommendations
Experience in creating recurring and ad-hoc reports
Independent judgment to resolve issues
Strong communication skills to work with management and key staff
Company
Cedars-Sinai
Since its beginning in 1902, Cedars-Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation, continually setting new standards for quality and innovation in patient care, research, teaching and community service.
Founded in 1902
10001+ employees
H1B Sponsorship
Cedars-Sinai has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (105)
2024 (91)
2023 (81)
2022 (92)
2021 (92)
2020 (65)
Funding
Current Stage
Late StageTotal Funding
$63.31MKey Investors
American Academy of Orthopaedic SurgeonsCalifornia HealthCare FoundationNational Heart, Lung and Blood Institute
2023-12-01Grant· $0.01M
2023-05-25Grant· $28M
2022-06-16Grant· $7M
Leadership Team
Thomas Priselac
President/CEO
David Wrigley
Executive Vice President Finance, CFO and Treasurer
Recent News
Medical Xpress - latest medical and health news stories
2025-12-17
Medical Xpress - latest medical and health news stories
2025-12-17
Company data provided by crunchbase